How many stocks are there of Merck KGaA?
The current number of stocks of Merck KGaA is 434.78 M undefined.
Merck KGaA Stocks 2024
Merck KGaA Stocks
434.78 M
Merck KGaA Dividend yield
1.5 %
Ticker
MRK.DE
ISIN
DE0006599905
WKN
659990
In 2024, Merck KGaA had 434.78 M outstanding stocks, a 0% change from the 434.78 M stocks in the previous year.
The Merck KGaA Stocks history
| YEAR | NUMBER OF STOCKS (undefined EUR) |
|---|---|
| 2029e | 434.78 |
| 2028e | 434.78 |
| 2027e | 434.78 |
| 2026e | 434.78 |
| 2025e | 434.78 |
| 2024e | 434.78 |
| 2023 | 434.78 |
| 2022 | 434.78 |
| 2021 | 434.57 |
| 2020 | 434.79 |
| 2019 | 434.21 |
| 2018 | 434.79 |
| 2017 | 434.78 |
| 2016 | 434.78 |
| 2015 | 434.78 |
| 2014 | 434.78 |
| 2013 | 435 |
| 2012 | 435 |
| 2011 | 435 |
| 2010 | 435 |
| 2009 | 435 |
| 2008 | 435 |
| 2007 | 432 |
| 2006 | 388 |
| 2005 | 388 |
| 2004 | 386 |
Merck KGaA Aktienanalyse
What does Merck KGaA do?
Merck is one of the oldest and most well-known companies in the pharmaceutical and chemical industry. It was founded as a pharmacy in Darmstadt in 1668 and has since developed into a global company that is successful worldwide. Merck's business model is based on various business areas, all of which are based on scientific research and innovation. The three main business areas are the Life Science, Healthcare, and Performance Materials divisions, all of which focus on providing products and services for a wide range of industries. Life Science is Merck's largest business area, focusing on providing materials, products, instruments, and services for scientific research and biopharmaceutical production. The company offers a wide range of products that focus on the work of researchers and scientists in molecular biology, cell technology, and genomics. Healthcare is another important business area for Merck, focusing on the manufacture and marketing of innovative drugs and treatments for patients. The company offers products for the treatment of diseases such as cancer, multiple sclerosis, and schizophrenia. Performance Materials is Merck's third business area, specializing in the production of materials and technologies for various industries such as the automotive industry, electronics, and packaging. The company focuses on the development of innovative materials such as liquid crystals and organic photovoltaic materials. Merck is also known for its research and development, and the company invests significant resources in developing new products and technologies. This is also evident in the extensive portfolio of products offered by Merck. The company offers a wide range of products ranging from laboratory and analysis equipment to pharmaceuticals and biopharmaceuticals to specialty chemicals. An example of an important product from Merck is the rheumatoid arthritis drug Remicade, which was developed in collaboration with Johnson & Johnson. Merck is also one of the leading manufacturers of liquid crystals for use in displays and electronic devices. Merck is a company committed to social responsibility and sustainability. The company is involved in many areas, including environmental, social, and governance issues. Merck is committed to developing sustainable products and technologies and is dedicated to promoting education, health, and social justice in the communities where it operates. Overall, Merck is a leading company in the pharmaceutical and chemical industry, known for its innovation, research and development, as well as its social responsibility and sustainability. With currently approximately 58,000 employees and annual sales of 17.4 billion euros, the global company network is represented in 67 countries and demonstrates the quality and capabilities of the company worldwide. Merck KGaA ist eines der beliebtesten Unternehmen auf Eulerpool.com.Merck KGaA revenue by segment
In the annual report of the Merck KGaA share (DE0006599905, 659990, MRK.DE), it breaks down its revenues into 3 segments: 1. Life Science, 2. Healthcare, 3. Performance Materials. The Merck KGaA stock (WKN: 659990, ISIN: DE0006599905, Ticker Symbol: MRK.DE) is a leading investment for investors interested in participating in the Health Care sector.
Stocks Details
Evaluating Merck KGaA's Shares Outstanding
Merck KGaA's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Merck KGaA’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Merck KGaA’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Merck KGaA’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Merck KGaA Stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Merck KGaA are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Merck KGaA evolved in recent years?
The number of shares of Merck KGaA has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Merck KGaA as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Merck KGaA?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Merck KGaA pay?
Over the past 12 months, Merck KGaA paid a dividend of 2.2 EUR . This corresponds to a dividend yield of about 1.5 %. For the coming 12 months, Merck KGaA is expected to pay a dividend of 2.42 EUR.
What is the dividend yield of Merck KGaA?
The current dividend yield of Merck KGaA is 1.5 %.
When does Merck KGaA pay dividends?
Merck KGaA pays a quarterly dividend. This is distributed in the months of May, May, June, May.
How secure is the dividend of Merck KGaA?
Merck KGaA paid dividends every year for the past 0 years.
What is the dividend of Merck KGaA?
For the upcoming 12 months, dividends amounting to 2.42 EUR are expected. This corresponds to a dividend yield of 1.65 %.
In which sector is Merck KGaA located?
Merck KGaA is assigned to the 'Health' sector.
Wann musste ich die Aktien von Merck KGaA kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Merck KGaA from 5/2/2024 amounting to 2.2 EUR, you needed to have the stock in your portfolio before the ex-date on 4/29/2024.
When did Merck KGaA pay the last dividend?
The last dividend was paid out on 5/2/2024.
What was the dividend of Merck KGaA in the year 2023?
In the year 2023, Merck KGaA distributed 1.85 EUR as dividends.
In which currency does Merck KGaA pay out the dividend?
The dividends of Merck KGaA are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Merck KGaA stock can be added to a savings plan with the following providers: Trade Republic, ING, Scalable Capital and Consorsbank
Andere Kennzahlen von Merck KGaA
Our stock analysis for Merck KGaA Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Merck KGaA Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
